Topic AllData science newsScience newsLife science newsNordic welfare newsHealth newsEducation newsLanguage & cultureSociety & economySustainability newsTeaching & studying at the UniversityHigher education & science policyHelsinki University Library Type AllNewsPress releaseIn briefEditorialArticleProfileEssayColumnCommentBooksSpeech Listing <span class="icon--list-as-blocks"></span><span class="icon--list"></span> Comment 27.4.2022 Health news Record number of publications for IVT Lab during 2021 and also superb start for the year 2022. Even if the pandemic has had a tremendous impact on everyday life in our lab in Helsinki we have been able to produce a record number of... Article 22.3.2022 Science news Rapid peptide discovery and ‘plug-and-play’ technology could make personalised cancer vaccines reality The new approach could help researchers quickly identify tumour-specific antigens recognised by cytotoxic T cells, generating a powerful,... Article 19.7.2021 Health news How Viruses Could Cure Cancer and Save Lives “When a virus is given to a tumor, the tumor becomes infected tissue,” says Vincenzo Cerullo, an oncolytic cancer vaccine immunologist at the... Article 19.7.2021 Life science news Immunotherapy among innovation, vanguard and creativity: Prof. Vincenzo Cerullo and his experience in Helsinki Immunotherapy has revolutionized the treatment of many cancers and research continues to make progress to find increasingly effective treatments... 29.10.2020 Health news Professor Vincenzo Cerullo as finalist in Falling Walls 2020 FALLING WALLS AND BERLIN SCIENCE WEEK THE WORLD SCIENCE SUMMIT Falling Walls and Berlin Science Week invites everyone to this year’s World... 30.6.2020 Health news Development of pan-corona vaccine against novel pandemic viruses Professor Vincenzo Cerullo held a talk at Tiedekulma 11th of June, 2020 about the development of a pan-corona vaccine 17.4.2020 Health news Professor Vincenzo Cerullo to lead development of vaccine for SARS-COV-2 The COVID-19 pandemic is an immediate global challenge and in the current crisis situation our focus has to be saving human lives and also... 8.4.2020 Science news Why commercialise? What are the benefits of commercialisation? Would it not be better just to publish the results? What do I need to commit to, if I wish to... 8.4.2020 Health news Open sesame coronavirus – researchers map the SARS-CoV-2 virus genome By studying the SARS-CoV-2 virus genome, we can acquire information regarding the rate of change of the virus or the size of its geographical... Pages1 2 3 Next
Comment 27.4.2022 Health news Record number of publications for IVT Lab during 2021 and also superb start for the year 2022. Even if the pandemic has had a tremendous impact on everyday life in our lab in Helsinki we have been able to produce a record number of...
Article 22.3.2022 Science news Rapid peptide discovery and ‘plug-and-play’ technology could make personalised cancer vaccines reality The new approach could help researchers quickly identify tumour-specific antigens recognised by cytotoxic T cells, generating a powerful,...
Article 19.7.2021 Health news How Viruses Could Cure Cancer and Save Lives “When a virus is given to a tumor, the tumor becomes infected tissue,” says Vincenzo Cerullo, an oncolytic cancer vaccine immunologist at the...
Article 19.7.2021 Life science news Immunotherapy among innovation, vanguard and creativity: Prof. Vincenzo Cerullo and his experience in Helsinki Immunotherapy has revolutionized the treatment of many cancers and research continues to make progress to find increasingly effective treatments...
29.10.2020 Health news Professor Vincenzo Cerullo as finalist in Falling Walls 2020 FALLING WALLS AND BERLIN SCIENCE WEEK THE WORLD SCIENCE SUMMIT Falling Walls and Berlin Science Week invites everyone to this year’s World...
30.6.2020 Health news Development of pan-corona vaccine against novel pandemic viruses Professor Vincenzo Cerullo held a talk at Tiedekulma 11th of June, 2020 about the development of a pan-corona vaccine
17.4.2020 Health news Professor Vincenzo Cerullo to lead development of vaccine for SARS-COV-2 The COVID-19 pandemic is an immediate global challenge and in the current crisis situation our focus has to be saving human lives and also...
8.4.2020 Science news Why commercialise? What are the benefits of commercialisation? Would it not be better just to publish the results? What do I need to commit to, if I wish to...
8.4.2020 Health news Open sesame coronavirus – researchers map the SARS-CoV-2 virus genome By studying the SARS-CoV-2 virus genome, we can acquire information regarding the rate of change of the virus or the size of its geographical...
